6-broMo-3-ethyl-iMidazo[1,2-a]pyrazine(1464091-69-7)
- Name: 6-broMo-3-ethyl-iMidazo[1,2-a]pyrazine
- Synonyms:6-broMo-3-ethyl-iMidazo[1,2-a]pyrazine
- Molecular Formula:C8H8BrN3
- Molecular Weight:226.07322
- CAS Registry Number:1464091-69-7
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1464091-69-7 6-Bromo-3-ethylimidazo[1,2-a]pyrazine
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.1464091-69-7 6-broMo-3-ethyl-iMidazo[1,2-a]pyrazine
Assay:NLT 98% Appearance:White powder Package:Aluminum bag/Carton Drum Storage:Store in a tightly closed container, in a cool and dry place. Transportation:By air Application:Used in producing API
Min. Order:0
Supplier:Hangzhou Huarong Pharm Co., Ltd. [
China (Mainland)] CAS No.1464091-69-7 6-Bromo-3-ethylimidazo[1,2-a]pyrazine
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal Chemistry Biomedicine Pharmaceutical intermediates Chemistry experiment Biological experiments Chemical reagent For R&D use only.
Min. Order:10Milligram
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)]
Other Product
- 442552-57-0/SALOR-INT L247367-1EA
- 1398338-67-4/methyl 4-chloro-5-iodo-2-(2-(phenylsulfonyl)acetamido)benzoate
- 923145-19-1/1-(4-METHOXYPYRIMIDIN-2-YL)PIPERIDINE-4-CARBOXYLIC ACID
- 1079264-82-6/2-chloro-N-(5-(diMethylaMino)-2-nitrophenyl)-5-nitrobenzaMide
- 27361-84-8/2-(chloroMethyl)-1-propyl-Pyrrolidine
- 921602-83-7/2,2-DIFLUOROCYCLOHEXANAMINE HYDROCHLORIDE
- 1368386-88-2/2-(2-Hydroxyphenyl)-[1,2,4]triazolo[1,5-a]pyridine-8-carboxylic acid
- 56800-08-9/(E)-1,3-Dichloro-1-butene
- 198630-68-1/D-Alanine, N-(2-methylpropyl)-, methyl ester (9CI)
- 186204-32-0/Lurasidone Inactive Metabolite 14283
- 8003-24-5/4-methoxy-3-tert-butyl-phenol
- 19729-27-2/3-[(Methoxycarbonylmethyl)thio]-N-(1-oxodecyl)-L-Ala-Gly-L-Val-OMe
- 343330-37-0/Ethanone, 1-[3-(1,1-dimethylethyl)-2,3-dihydro-2-furanyl]- (9CI)
- 697287-41-5/(S)-N-[1-(4-Cyclopropylmethyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-ethyl]-3-(2-fluoro-phenyl)acrylamide
- 1312535-18-4/3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
- 205810-25-9/pyrene-1,6-diyldiboronic acid
- 1158750-51-6/1,7-Diazaspiro[4.5]decane, 1-Methyl-
- 1464091-69-7/6-broMo-3-ethyl-iMidazo[1,2-a]pyrazine
- 154644-14-1/PANTOPRAZOLE SODIUM SESQUIHYDRATE
- 697242-36-7/3-(1H-IMIDAZOL-1-YL)-6-METHOXYPYRIDAZINE
- 1142205-12-6/[(2-oxo-2-{[4-(trifluoromethyl)benzyl]amino}ethyl)(phenyl)amino]acetic acid
- 148888-26-0/Piperidine, 4-[2-(1-methylethoxy)phenyl]-
- 1154742-51-4/5-bromo-4,6-difluoro-1H-indole
- 1392745-47-9/Ethyl (1S,3R,4R)4{[(tertbutoxy)carbonyl]aMino}3hydroxycyclohexane1carboxylate
- 64651-44-1/Beryllium trifluoride
- 860176-01-8/1-Methyl-1H-1,2,3-triazol-4-aMine Hydrochloride
- 119623-76-6/1,2,5,8,9,10-Hexahydro-5,10-dioxo-4,6-dipropylpyrido[3,2-g]quinoline-3,7-diacetic acid
- 35558-60-2/2-Methylphenyl β-D-glucopyranoside 3,4,6-triacetate 2-benzoate
- 334933-44-7/METHYL 5-(TERT-BUTYLDIMETHYLSILYLOXYMETHYL-2,6-DIISOPROPYL-4-(4-FLUOROPHENYL)-PYRIDINE-3-CARBOXYLATE
- 464190-33-8/4-BROMO-2'-CHLOROBENZOPHENONE